Yes, ancient history, all the way back to December 2022
Done by a team of 12 UCSD Doctors.
Brian M. Ilfeld MD, MS (Clinical Investigation) Engy T. Said MD Rodney A. Gabriel MD, MAS (Clinical Research) Brian P. Curran MD Matthew W. Swisher MD MS, Garth R. Jacobsen MD Anne M. Wallace MD Jay Doucet MD, FRCSC, FACS Laura M. Adams MD, George J. Ventro MD Baharin Abdullah MD John J. Finneran IV MD
I will go with the findings and the opinion of Dr Brian Ilfeld, who has done dozens and dozens of clinical studies,
"Six patients avoided opioid use entirely, while the remaining individual required only 5 mg of oxycodone during the first postoperative day."
"These cases demonstrate that the ambulatory use of pulsed shortwave devices is feasible and may be an effective analgesic, possibly obviating opioid requirements following outpatient herniorrhaphy and breast surgery. Considering the lack of any side effects, adverse events, and misuse/dependence/diversion potential, further study with a randomized, controlled trial appears warranted."